相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
Chris Estes et al.
HEPATOLOGY (2018)
Liver-directed microRNA-7a depletion induces nonalcoholic fatty liver disease by stabilizing YY1-mediated lipogenic pathways in zebrafish
Chi-Yu Lai et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2018)
The Small Intestine Converts Dietary Fructose into Glucose and Organic Acids
Cholsoon Jang et al.
CELL METABOLISM (2018)
The Natural History of Nonalcoholic Fatty Liver Disease-An Evolving View
Christina C. Lindenmeyer et al.
CLINICS IN LIVER DISEASE (2018)
The Intestinal Microbiome in Nonalcoholic Fatty Liver Disease
Puneet Puri et al.
CLINICS IN LIVER DISEASE (2018)
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science
Mohammad Shadab Siddiqui et al.
HEPATOLOGY (2018)
A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis
Scott L. Friedman et al.
HEPATOLOGY (2018)
Nonalcoholic fatty liver disease incidence and impact on metabolic burden and death: A 20 year-community study
Alina M. Allen et al.
HEPATOLOGY (2018)
Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice
Phillipp Hartmann et al.
HEPATOLOGY (2018)
Translating scientific discovery: the need for preclinical models of nonalcoholic steatohepatitis
Abdul M. Oseini et al.
HEPATOLOGY INTERNATIONAL (2018)
Lipotoxicity and the gut-liver axis in NASH pathogenesis
Fabio Marra et al.
JOURNAL OF HEPATOLOGY (2018)
Pharmacotherapy for NASH: Current and emerging
Monica A. Konerman et al.
JOURNAL OF HEPATOLOGY (2018)
Genetics and epigenetics of NAFLD and NASH: Clinical impact
Mohammed Eslam et al.
JOURNAL OF HEPATOLOGY (2018)
Preclinical models of non-alcoholic fatty liver disease
Prasanna K. Santhekadur et al.
JOURNAL OF HEPATOLOGY (2018)
A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer
Takuma Tsuchida et al.
JOURNAL OF HEPATOLOGY (2018)
NGM282 for treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Stephen A. Harrison et al.
LANCET (2018)
A Protein-Truncating HSD17B13 Variant and Protection from Chronic Liver Disease
N. S. Abul-Husn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
ERRγ Preserves Brown Fat Innate Thermogenic Activity
Maryam Ahmadian et al.
CELL REPORTS (2018)
Hepatocyte-secreted DPP4 in obesity promotes adipose inflammation and insulin resistance
Devram S. Ghorpade et al.
NATURE (2018)
Bile Acids and Nonalcoholic Fatty Liver Disease: Molecular Insights and Therapeutic Perspectives
Juan P. Arab et al.
HEPATOLOGY (2017)
Fibroblast Growth Factor 21-Metabolic Role in Mice and Men
Harald Staiger et al.
ENDOCRINE REVIEWS (2017)
Changes in the Prevalence of Hepatitis C Virus Infection, Nonalcoholic Steatohepatitis, and Alcoholic Liver Disease Among Patients With Cirrhosis or Liver Failure on the Waitlist for Liver Transplantation
David Goldberg et al.
GASTROENTEROLOGY (2017)
Using Big Data to Discover Diagnostics and Therapeutics for Gastrointestinal and Liver Diseases
Benjamin Wooden et al.
GASTROENTEROLOGY (2017)
Metabolomic Identification of Subtypes of Nonalcoholic Steatohepatitis
Cristina Alonso et al.
GASTROENTEROLOGY (2017)
Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity
Jean-Marc Schwarz et al.
GASTROENTEROLOGY (2017)
Baseline Parameters in Clinical Trials for Nonalcoholic Steatohepatitis: Recommendations From the Liver Forum
Yuval A. Patel et al.
GASTROENTEROLOGY (2017)
The PNPLA3 I148M Variant Modulates the Fibrogenic Phenotype of Human Hepatic Stellate Cells
Francesca Virginia Bruschi et al.
HEPATOLOGY (2017)
The PNPLA3 Variant Associated With Fatty Liver Disease (I148M) Accumulates on Lipid Droplets by Evading Ubiquitylation
Soumik BasuRay et al.
HEPATOLOGY (2017)
Mutant PNPLA3 I148M Protein as Pharmacological Target for Liver Disease
Luca Valenti et al.
HEPATOLOGY (2017)
Metabolic and Histological Implications of Intrahepatic Triglyceride Content in Nonalcoholic Fatty Liver Disease
Fernando Bril et al.
HEPATOLOGY (2017)
Interactions between bile salts, gut microbiota, and hepatic innate immunity
Kristin Schubert et al.
IMMUNOLOGICAL REVIEWS (2017)
Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis
Cyrielle Caussy et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD
Hannes Hagstrom et al.
JOURNAL OF HEPATOLOGY (2017)
NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
Auvro R. Mridha et al.
JOURNAL OF HEPATOLOGY (2017)
Association betweenMRI-derived hepatic fat fraction and blood pressure in participants without history of cardiovascular disease
Roberto Lorbeer et al.
JOURNAL OF HYPERTENSION (2017)
Non-alcoholic fatty liver disease with and without metabolic syndrome: Different long-term outcomes
Aki Juhani Karajamaki et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2017)
Commensal bacteria make GPCR ligands that mimic human signalling molecules
Louis J. Cohen et al.
NATURE (2017)
Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci
Stefan Stender et al.
NATURE GENETICS (2017)
Thermoneutral housing exacerbates nonalcoholic fatty liver disease in mice and allows for sex-independent disease modeling
Daniel A. Giles et al.
NATURE MEDICINE (2017)
Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention
Ruixin Liu et al.
NATURE MEDICINE (2017)
Mechanisms of hepatic stellate cell activation
Takuma Tsuchida et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Clinical relevance of the bile acid receptor TGR5 in metabolism
F. Samuel van Nierop et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Nonalcoholic fatty liver disease and increased risk of 1-year all-cause and cardiac hospital readmissions in elderly patients admitted for acute heart failure
Filippo Valbusa et al.
PLOS ONE (2017)
Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation
Chai-Wan Kim et al.
CELL METABOLISM (2017)
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition
Anuradha Krishnan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Obesity-induced hepatic steatosis is mediated by endoplasmic reticulum stress in the subfornical organ of the brain
Julie A. Horwath et al.
JCI INSIGHT (2017)
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease
Rohit Loomba et al.
CELL METABOLISM (2017)
Intestinal microbiota and nonalcoholic steatohepatitis
Katharina Brandl et al.
CURRENT OPINION IN GASTROENTEROLOGY (2017)
Genetic predisposition in nonalcoholic fatty liver disease
Silvia Sookoian et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2017)
Inhibition of sphingosine 1-phosphate signaling ameliorates murine nonalcoholic steatohepatitis
Amy S. Mauer et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2017)
Non-alcoholic fatty liver disease
Brent A. Neuschwander-Tetri
BMC MEDICINE (2017)
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study
Raymond Kwok et al.
GUT (2016)
Beneficial effects of combined ursodeoxycholic acid and angiotensin-II type 1 receptor blocker on hepatic fibrogenesis in a rat model of nonalcoholic steatohepatitis
Tadashi Namisaki et al.
JOURNAL OF GASTROENTEROLOGY (2016)
The roles of c-Jun NH2-terminal kinases (JNKs) in obesity and insulin resistance
Martin Pal et al.
JOURNAL OF PHYSIOLOGY-LONDON (2016)
Molecular Liver Cancer Prevention in Cirrhosis by Organ Transcriptome Analysis and Lysophosphatidic Acid Pathway Inhibition
Shigeki Nakagawa et al.
CANCER CELL (2016)
Effects of Moderate and Subsequent Progressive Weight Loss on Metabolic Function and Adipose Tissue Biology in Humans with Obesity
Faidon Magkos et al.
CELL METABOLISM (2016)
Hepatocyte TAZ/WWTR1 Promotes Inflammation and Fibrosis in Nonalcoholic Steatohepatitis
Xiaobo Wang et al.
CELL METABOLISM (2016)
Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease
Sahil Mittal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2016)
Role of Dietary Fructose and Hepatic De Novo Lipogenesis in Fatty Liver Disease
Samir Softic et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Cardiovascular Disease and Myocardial Abnormalities in Nonalcoholic Fatty Liver Disease
Alessandro Mantovani et al.
DIGESTIVE DISEASES AND SCIENCES (2016)
Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening
Vlad Ratziu et al.
GASTROENTEROLOGY (2016)
Changes in the Intestinal Microbiome and Alcoholic and Nonalcoholic Liver Diseases: Causes or Effects?
Naga S. Betrapally et al.
GASTROENTEROLOGY (2016)
Thyroid Hormone Receptor β Agonist Induces β-Catenin-Dependent Hepatocyte Proliferation in Mice: Implications in Hepatic Regeneration
Tamara Feliciano Alvarado et al.
GENE EXPRESSION (2016)
The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
The Severity of Nonalcoholic Fatty Liver Disease Is Associated With Gut Dysbiosis and Shift in the Metabolic Function of the Gut Microbiota
Jerome Boursier et al.
HEPATOLOGY (2016)
Clinical Patterns of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease: A Multicenter Prospective Study
Fabio Piscaglia et al.
HEPATOLOGY (2016)
The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Varman T. Samuel et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
Stefano Ballestri et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
A diet-induced animal model of non-alcoholic fatty liver disease and hepatocellular cancer
Amon Asgharpour et al.
JOURNAL OF HEPATOLOGY (2016)
Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis
Giovanni Targher et al.
JOURNAL OF HEPATOLOGY (2016)
Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
Panu K. Luukkonen et al.
JOURNAL OF HEPATOLOGY (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death The role of ER stress in lipid metabolism and lipotoxicity
Jaeseok Han et al.
JOURNAL OF LIPID RESEARCH (2016)
Thematic Review Series: Lipotoxicity: Many Roads to Cell Dysfunction and Cell Death Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Petra Hirsova et al.
JOURNAL OF LIPID RESEARCH (2016)
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
Matthew James Armstrong et al.
LANCET (2016)
Molecular mechanisms of lipotoxicity and glucotoxicity in nonalcoholic fatty liver disease
Manoela Mota et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The role of the gut microbiota in NAFLD
Christopher Leung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Management of NAFLD: a stage-based approach
Mary E. Rinella et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2016)
Complex genetics of pulmonary diseases: lessons from genome-wide association studies and next-generation sequencing
Nima Pouladi et al.
TRANSLATIONAL RESEARCH (2016)
The Role of Cholesterol in the Pathogenesis of NASH
George N. Ioannou
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2016)
Non-alcoholic fatty liver and the gut microbiota
Stavros Bashiardes et al.
MOLECULAR METABOLISM (2016)
Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease
Serena Pelusi et al.
PLOS ONE (2016)
Bioprinted 3D Primary Liver Tissues Allow Assessment of Organ-Level Response to Clinical Drug Induced Toxicity In Vitro
Deborah G. Nguyen et al.
PLOS ONE (2016)
Development of an in vitro human liver system for interrogating nonalcoholic steatohepatitis
Ryan E. Feaver et al.
JCI INSIGHT (2016)
Brown and Beige Fat: Physiological Roles beyond Heat Generation
Shingo Kajimura et al.
CELL METABOLISM (2015)
Fibrosis Progression in Nonalcoholic Fatty Liver vs Nonalcoholic Steatohepatitis: A Systematic Review and Meta-analysis of Paired-Biopsy Studies
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
Jessica Bazick et al.
DIABETES CARE (2015)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study
Rohit Loomba et al.
GASTROENTEROLOGY (2015)
Nonalcoholic Steatohepatitis Is the Second Leading Etiology of Liver Disease Among Adults Awaiting Liver Transplantation in the United States
Robert J. Wong et al.
GASTROENTEROLOGY (2015)
Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease
Paul Angulo et al.
GASTROENTEROLOGY (2015)
Association of nonalcoholic fatty liver disease with subclinical myocardial remodeling and dysfunction: A population-based study
Lisa B. VanWagner et al.
HEPATOLOGY (2015)
Challenges and Opportunities in Drug and Biomarker Development for Nonalcoholic Steatohepatitis: Findings and Recommendations From an American Association for the Study of Liver Diseases-US Food and Drug Administration Joint Workshop
Arun J. Sanyal et al.
HEPATOLOGY (2015)
Fibrosis Stage Is the Strongest Predictor for Disease-Specific Mortality in NAFLD After Up to 33 Years of Follow-Up
Mattias Ekstedt et al.
HEPATOLOGY (2015)
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels
Paola Portillo-Sanchez et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management
Stuart McPherson et al.
JOURNAL OF HEPATOLOGY (2015)
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
Brent A. Neuschwander-Tetri et al.
LANCET (2015)
Inflammasome activation and function in liver disease
Gyongyi Szabo et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2015)
Controlled-release mitochondrial protonophore reverses diabetes and steatohepatitis in rats
Rachel J. Perry et al.
SCIENCE (2015)
Liraglutide, a Glucagon-Like Peptide-1 Analog, Increased Insulin Sensitivity Assessed by Hyperinsulinemic-Euglycemic Clamp Examination in Patients with Uncontrolled Type 2 Diabetes Mellitus
Hideaki Jinnouchi et al.
JOURNAL OF DIABETES RESEARCH (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis
Fernando J. Barreyro et al.
LIVER INTERNATIONAL (2015)
Long term follow-up and liver-related death rate in patients with non-alcoholic and alcoholic related fatty liver disease
Svanhildur Haflidadottir et al.
BMC GASTROENTEROLOGY (2014)
ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development
Hayato Nakagawa et al.
CANCER CELL (2014)
The Fatty Acid-Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease
Rifaat Safadi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Contributions of metabolic dysregulation and inflammation to nonalcoholic steatohepatitis, hepatic fibrosis, and cancer
Abigale Lade et al.
CURRENT OPINION IN ONCOLOGY (2014)
Hepatocellular cancer: The impact of obesity, type 2 diabetes and a multidisciplinary team
Jessica Dyson et al.
JOURNAL OF HEPATOLOGY (2014)
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Rachel J. Perry et al.
NATURE (2014)
Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
Giovanni Musso et al.
PLOS MEDICINE (2014)
Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome
Hannele Yki-Jarvinen
LANCET DIABETES & ENDOCRINOLOGY (2014)
Diet-induced mouse model of fatty liver disease and nonalcoholic steatohepatitis reflecting clinical disease progression and methods of assessment
Jason R. Clapper et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Lipid lowering in healthy volunteers treated with multiple doses of MGL-3196, a liver-targeted thyroid hormone receptor-β agonist
Rebecca Taub et al.
ATHEROSCLEROSIS (2013)
Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease
Sunder Mudaliar et al.
GASTROENTEROLOGY (2013)
An improved mouse model that rapidly develops fibrosis in non-alcoholic steatohepatitis
Masahiko Matsumoto et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2013)
Role of Fat Body Lipogenesis in Protection against the Effects of Caloric Overload in Drosophila
Laura Palanker Musselman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver
Raluca Pais et al.
JOURNAL OF HEPATOLOGY (2013)
Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis
Quentin M. Anstee et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
The global NAFLD epidemic
Rohit Loomba et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
A murine model for non-alcoholic steatohepatitis showing evidence of association between diabetes and hepatocellular carcinoma
Masato Fujii et al.
MEDICAL MOLECULAR MORPHOLOGY (2013)
Obstructive Sleep Apnea Is Associated with Fatty Liver and Abnormal Liver Enzymes: a Meta-analysis
Silvia Sookoian et al.
OBESITY SURGERY (2013)
JNK Expression by Macrophages Promotes Obesity-Induced Insulin Resistance and Inflammation
Myoung Sook Han et al.
SCIENCE (2013)
Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice
James L. Trevaskis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2012)
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
Kenneth Cusi
GASTROENTEROLOGY (2012)
Hedgehog pathway activation parallels histologic severity of injury and fibrosis in human nonalcoholic fatty liver disease
Cynthia D. Guy et al.
HEPATOLOGY (2012)
Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes
Manal F. Abdelmalek et al.
HEPATOLOGY (2012)
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
Rohit Loomba et al.
HEPATOLOGY (2012)
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
Romina Lomonaco et al.
HEPATOLOGY (2012)
Uric Acid Induces Hepatic Steatosis by Generation of Mitochondrial Oxidative Stress POTENTIAL ROLE IN FRUCTOSE-DEPENDENT AND -INDEPENDENT FATTY LIVER
Miguel A. Lanaspa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
The lipogenic transcription factor ChREBP dissociates hepatic steatosis from insulin resistance in mice and humans
Fadila Benhamed et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity
Jorge Henao-Mejia et al.
NATURE (2012)
Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition
Michael Charlton et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2011)
Genetic modifiers of non-alcoholic fatty liver disease progression
Quentin M. Anstee et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Fatty Acid and Endotoxin Activate Inflammasomes in Mouse Hepatocytes that Release Danger Signals to Stimulate Immune Cells
Timea Csak et al.
HEPATOLOGY (2011)
The role of thiazolidinediones in non-alcoholic steatohepatitis - A systematic review and meta analysis
Suzanne E. Mahady et al.
JOURNAL OF HEPATOLOGY (2011)
Dietary cholesterol exacerbates hepatic steatosis and inflammation in obese LDL receptor-deficient mice
Savitha Subramanian et al.
JOURNAL OF LIPID RESEARCH (2011)
Development of Novel Combination Therapies
Janet Woodcock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inflammasome is a central player in the induction of obesity and insulin resistance
Rinke Stienstra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Apoptosis in nonalcoholic fatty liver disease: diagnostic and therapeutic implications
Naim Alkhouri et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2011)
Predicting Fibrosis Worsening in Obese Patients With NASH Through Parenchymal Fibronectin, HOMA-IR, and Hypertension
Paolo Sorrentino et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
The Role of Cytokines in Non-Alcoholic Fatty Liver Disease
Herbert Tilg
DIGESTIVE DISEASES (2010)
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (FLIRT 2) Extension Trial
Vlad Ratziu et al.
HEPATOLOGY (2010)
Hepatic Lipotoxicity and the Pathogenesis of Nonalcoholic Steatohepatitis: the Central Role of Nontriglyceride Fatty Acid Metabolites
Brent A. Neuschwander-Tetri
HEPATOLOGY (2010)
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis.
Arun J. Sanyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
A comprehensive definition for metabolic syndrome
Paul L. Huang
DISEASE MODELS & MECHANISMS (2009)
Importance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis
Amalia Gastaldelli et al.
HEPATOLOGY (2009)
Nutritional Model of Steatohepatitis and Metabolic Syndrome in the Ossabaw Miniature Swine
Lydia Lee et al.
HEPATOLOGY (2009)
Adipokines in Liver Diseases
Fabio Marra et al.
HEPATOLOGY (2009)
Fatty acid metabolism: target for metabolic syndrome
Salih J. Wakil et al.
JOURNAL OF LIPID RESEARCH (2009)
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
Bo Kong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Activation and dysregulation of the unfolded protein response in nonalcoholic fatty liver disease
Puneet Puri et al.
GASTROENTEROLOGY (2008)
Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Stefano Romeo et al.
NATURE GENETICS (2008)
A Stress Signaling Pathway in Adipose Tissue Regulates Hepatic Insulin Resistance
Guadalupe Sabio et al.
SCIENCE (2008)
Lysophosphatidylcholine as a death effector in the lipoapoptosis of hepatocytes
Myoung Sook Han et al.
JOURNAL OF LIPID RESEARCH (2008)
Ability of the normal human small intestine to absorb fructose: Evaluation by breath testing
Satish S. C. Rao et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Transgenic mice expressing nuclear sterol regulatory element-binding protein 1c in adipose tissue exhibit liver histology similar to nonalcoholic steatohepatitis
Hitomi Nakayama et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2007)
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Mattias Ekstedt et al.
HEPATOLOGY (2006)
Adaptive failure to high-fat diet characterizes steatohepatitis in Alms1 mutant mice
T Arsov et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
QM Anstee et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2006)
Insulin resistance: A metabolic pathway to chronic liver disease
E Bugianesi et al.
HEPATOLOGY (2005)
Physiological difference between obese (fa/fa) Zucker rats and lean Zucker rats concerning adiponectin
F Oana et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
NASH: a mitochondrial disease
D Pessayre et al.
JOURNAL OF HEPATOLOGY (2005)
The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
LA Adams et al.
JOURNAL OF HEPATOLOGY (2005)
Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities
AJ Sanyal et al.
GASTROENTEROLOGY (2001)
Liver fibrosis in overweight patients
V Ratziu et al.
GASTROENTEROLOGY (2000)
分享论文
